ATAI Life Sciences AG, a global biotechnology company builder that envisions an end to mental illnesses, today announced that it will host a virtual Research and Development (R&D) Day for analysts and investors on Wednesday, July 29, 2020 from 12:00pm to 3:00pm ET.
ATAI Life Sciences to Host Virtual R&D Day on July 29, 2020
atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders
atai Life Sciences, a global biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, has acquired a…
JOIN THE ATAI #INSIGHTNETWORK